Antag Therapeutics ApS

Antag Therapeutics is based on years of collaborative research from the University of Copenhagen with the focus on novel treatments for dietary-related metabolic diseases. The research teams of professors Mette Rosenkilde and Jens Juul Holst have discovered naturally occurring therapeutic peptides that are being investigated in several human studies.

Our mission is to develop first-in-class peptide drugs for the treatment of dietary-related metabolic diseases. Our drugs are based on a novel, effective, naturally occurring antagonist that modulates fat deposition and dysregulation of glycemia in diabetic patients.

Contact name:

Alexander Sparre-Ulrich, CEO


Ole Maaløes vej 3, 2200 Copenhagen N, Denmark





Number of employees:


If you cannot find what you are looking for or if you have feedback to our website, please do not hesitate to contact or +45 7172 1114

Copyright 2018 DANISH BIO – DANSK BIOTEK. All rights reserved.